Meet GOLD's new catalyst – GSK's John Wahba
Season 03: episode 14
In this week’s episode, Helena and Isabel share an interview with GOLD’s new catalyst John Wahba, Medical Head of the Global Digital Hub, GSK. In this teaser edition of the catalyst interview, John shares his motivations for joining the pharmaceutical industry, key takeaways from his time in the medical field, thoughts on digitally optimising MSL teams and much more.
In addition, in 'news you might've missed', the team shares stories about a new drug approval for the treatment of lupus nephritis, the productivity of the UK life sciences sector and AstraZeneca's acquisition of Neogene Therapeutics Inc.
A little more on GOLD’s guest…
John Wahba is Medical Head of the Global Digital Hub, GSK. In this role, he works with the company’s global teams to support the execution of digital engagement and omnichannel optimisation. Starting out his career in medicine, John worked as a doctor in obstetrics and gynaecology at Imperial College London, before joining the medical affairs function in 2016. Ever since then, his career has taken him to a multitude of companies, including Bayer and ViiV Healthcare, and he took on his current role at GSK in 2022. John has a strong passion for innovation and improving healthcare for all, and he also acts as an ABPI final signatory.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Click here to subscribe to the weekly newsletter for more insights from GOLD.